{"pageContent": "Background: Radium-223 dichloride (Ra-223) is now frequently used to treat prostate cancer that has metastasized to bone, although patient selection continues to be suboptimal for determining who will benefit most from this novel treatment modality.", "metaData": {"source": "Two Black men with prostate cancer: a narrative approach\nhttps://pubmed.ncbi.nlm.nih.gov/15826335/"}}